Long-term cognitive benefits of donepezil in Alzheimer?s disease: A retrospective comparison between 1994?1999 and 2000?2004

Autor: Masako Tamamizu, Masahiro Maruyama, Koh Iwasaki, Mari Ootsuki, Naoki Tomita, Miho Tsutsui, Miyako Higuchi, Isao Yoshimura, Katsutoshi Furukawa, Takashi Seki, Toshifumi Matsui, Takashi Sozu, Hiroyuki Arai
Rok vydání: 2007
Předmět:
Zdroj: Geriatrics & Gerontology International. 7:41-47
ISSN: 1447-0594
1444-1586
Popis: Objective: In order to address an issue of how long Alzheimer’s disease (AD) patients should receive donepezil, we estimated long-term effect of donepezil on cognition as well as its influential factors. We also evaluated the additional effect of cerebrospinal fluid (CSF)-tau protein levels on diagnosis. Methods: We compared cognitive changes between current (2000–2004) AD patients (donepezil users) and previous AD patients, seen by us 1994–1999, without receiving donepezil (non-donepezil users) by a mixed effect model. Cognition was assessed by Mini-Mental State Examination (MMSE) at 6-month intervals up to 24 months. Sensitivity analysis was performed exclusively on patients with high CSF-tau protein levels (CSF-tau >330 pg/mL) to minimize inaccuracies of the diagnosis Results: From 495 AD patients reviewed, 192 patients (120 donepezil users and 72 controls) were eligible. Estimated annual decline of MMSE was 1.2 points (95% confidence interval (95%CI), 0.9–1.5) in the donepezil users, whereas it was 2.8 points (95%CI, 2.1–3.6) in the control group. The difference was statistically significant (P
Databáze: OpenAIRE
Externí odkaz: